** Shares of vTv Therapeutics Inc VTVT.O up 13% at 81
cents premarket, above their 150-day moving average price of 72
cents
** VTVT says CinRx Pharma to invest $10 million to acquire
4.2 million of VTVT shares at $2.41/shr, a more than 200%
premium to stock's last closing price urn:newsml:reuters.com:*:nGNX4sZrlR
** Says investment brings a partner to help speed up
development of its treatment, TTP399, for diabetes patients
** As of Friday's closing price, stock had fallen 27.7% this
year
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))